Puma Biotechnology Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance
November 2, 2023 4:55 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.18, $0.10 better than the analyst estimate of $0.08. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $57.95 million.
GUIDANCE:
Puma Biotech sees FY2023 revenue of $206-209 million, versus the consensus... More
